Back to Search
MING-JYI TSAO, MD
MD
Pain Medicine (Anesthesiology) Physician
NPI: 1932210044Individual
Specialties, Licenses & Credentials
Pain Medicine (Anesthesiology) PhysicianPrimary
Anesthesiology — Pain Medicine
Code: 207LP2900X
ME26390(FL)
Research & Publications (20)
Physician expectations of treatment outcomes for patients with brain metastases referred for whole brain radiotherapy.
PMID 19386437·Int J Radiat Oncol Biol Phys·2010
8-other
Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
PMID 19427055·Lung Cancer·2010
8-other
Clinical evaluation of stereotactic target localization using 3-Tesla MRI for radiosurgery planning.
PMID 19515512·Int J Radiat Oncol Biol Phys·2010
8-other
Exploration of symptoms clusters within cancer patients with brain metastases using the Spitzer Quality of Life Index.
PMID 19484486·Support Care Cancer·2010
8-other
A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation.
PMID 19499221·Cancer Chemother Pharmacol·2010
3-trial
Elderly patients with painful bone metastases should be offered palliative radiotherapy.
PMID 19540056·Int J Radiat Oncol Biol Phys·2010
8-other
Change in urinary markers of osteoclast activity following palliative radiotherapy for bone metastases.
PMID 19250812·Clin Oncol (R Coll Radiol)·2009
4-observational
Dexamethasone for the prophylaxis of radiation-induced pain flare after palliative radiotherapy for symptomatic bone metastases: a phase II study.
PMID 19232483·Clin Oncol (R Coll Radiol)·2009
3-trial
Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib.
PMID 19309723·Head Neck·2009
3-trial
Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer.
PMID 19435915·Cancer Res·2009
7-preclinical
Overview of molecular testing in non-small-cell lung cancer: mutational analysis, gene copy number, protein expression and other biomarkers of EGFR for the prediction of response to tyrosine kinase inhibitors.
PMID 19680292·Oncogene·2009
6-review
Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
PMID 19224855·J Clin Oncol·2009
8-other
The role of the epidermal growth factor receptor tyrosine kinase inhibitors as therapy for advanced, metastatic, and recurrent non-small-cell lung cancer: a Canadian national consensus statement.
PMID 19229369·Curr Oncol·2009
8-other
Mechanistic studies of the immunochemical termination of self-tolerance with unnatural amino acids.
PMID 19246393·Proc Natl Acad Sci U S A·2009
7-preclinical
Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy.
PMID 19231099·Int J Radiat Oncol Biol Phys·2009
8-other
Summary of selected presentations from the 8th annual targeted therapy in lung cancer symposium.
PMID 19550249·J Thorac Oncol·2009
8-other
Advances in technology for intracranial stereotactic radiosurgery.
PMID 19645520·Technol Cancer Res Treat·2009
6-review
Enhancement of survival of probiotic and non-probiotic lactic acid bacteria by yeasts in fermented milk under non-refrigerated conditions.
PMID 19666198·Int J Food Microbiol·2009
8-other
Inhibition of spoilage yeasts in cheese by killer yeast Williopsis saturnus var. saturnus.
PMID 19349088·Int J Food Microbiol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 E DIXIE AVE
LEESBURG, FL 34748 - Phone
- (352) 867-8898
Quick Facts
- NPI
- 1932210044
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile